D-0379-2015 Class II Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- January 28, 2015
- Initiation Date
- December 31, 2014
- Termination Date
- October 4, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,428 vials
Product Description
Virazole (Ribavirin for Inhalation Solution, USP), Sterile Lyophilized For Administration by Aerosol Inhalation Only, Rx only, Contents: Four 6 g vials, 100 mL, Distributed by: Valeant Pharmaceuticals North America, Bridgewater, NJ 08807 USA, NDC 0187-0007-14.
Reason for Recall
Non-Sterility: Valeant's laboratory observed a positive microbial contamination of Virazole lot 340353F, during testing at the 12 month stability pull.
Distribution Pattern
Nationwide and Australia
Code Information
Lot #: 340353F, Exp 10/2018